After a delay, the FDA has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately ...

Neither party wants to be perceived as threatening Medicare. The Biden administration has taken steps to reduce payment to ...

Jeffrey Dunn, Pharm.D., MBA, discusses how comparison trials for different assisted reproductive technologies (ARTs) are necessary to evaluate their relative efficacy, safety and cost-effectiveness, ...

The key opinion leader discusses how criteria for assisted reproductive technology (ART) coverage are established, including stepwise approaches and considerations for mixed protocols, while ...

The Democrats have expanded the program under the Affordable Care Act. Republicans have proposed cuts in federal funding and work requirements.

KarXT — now with the brand name Cobenfy— is expected to be available in October with a list price of about $22,500 annually. The drug represents a new way to treat adults with schizophrenia.

Employment satisfaction, sleep quality and lack of physical movement were all tied to vitality levels, survey results show.

The Phase I/II trials for rare forms of hereditary blindness further confirmed the potential for gene therapy treatments of ...

The FDA approved IntraBio Inc.'s Aqneursa (levacetylleucine) yesterday for the treatment of ultra rare neurodegenerative ...

A study found omitting a course of antibiotic prophylaxis was non-inferior to the routinely administering antibiotics in ...

Novo Nordisk said it’s open to discussions with PBMs based on their commitments that a lower semgalutide list price would not ...

Results looking at the first season of RSV use shows that it is 75% effective at preventing RSV-associated hospitalizations ...